Skip to content
World of Video Gaming – Lifestyle
Home
Sample Page
Author:
Accro Bioscience Inc.
Accro Bioscience to Present Phase Ib Data of AC-101, an Oral Selective RIPK2 Inhibitor, for Moderate-to-Severe UC at UEG Week 2026 in Barcelona
August 13, 2026